{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:10:52Z","timestamp":1790205052436,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep03363","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T05:03:51Z","timestamp":1385615031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection"],"prefix":"10.1038","volume":"3","author":[{"given":"Chidchamai","family":"Kewcharoenwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darawan","family":"Rinchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusumawadee","family":"Utispan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangchan","family":"Suwannasaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganjana","family":"Lertmemongkolchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"BFsrep03363_CR1","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","volume":"341","author":"N Joshi","year":"1999","unstructured":"Joshi, N., Caputo, G. M., Weitekamp, M. R. & Karchmer, A. W. Infections in Patients with Diabetes Mellitus. New England Journal of Medicine 341, 1906\u20131912 (1999).","journal-title":"New England Journal of Medicine"},{"key":"BFsrep03363_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.26.2.510","volume":"26","author":"BR Shah","year":"2003","unstructured":"Shah, B. R. & Hux, J. E. Quantifying the Risk of Infectious Diseases for People With Diabetes. Diabetes Care 26, 510\u2013513 (2003).","journal-title":"Diabetes Care"},{"key":"BFsrep03363_CR3","unstructured":"Koh, G., Peacock, S. J., Poll, T. & Wiersinga, W. J. The impact of diabetes on the pathogenesis of sepsis. European Journal of Clinical Microbiology & Infectious Diseases, 1\u201310 (2011)."},{"key":"BFsrep03363_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1086\/520223","volume":"29","author":"Y Suputtamongkol","year":"1999","unstructured":"Suputtamongkol, Y. et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 29, 408\u2013413 (1999).","journal-title":"Clin Infect Dis"},{"key":"BFsrep03363_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","volume":"18","author":"AC Cheng","year":"2005","unstructured":"Cheng, A. C. & Currie, B. J. Melioidosis: Epidemiology, Pathophysiology and Management. Clin. Microbiol. Rev. 18, 383\u2013416 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFsrep03363_CR6","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","volume":"361","author":"NJ White","year":"2003","unstructured":"White, N. J. Melioidosis. Lancet 361, 1715\u20131722 (2003).","journal-title":"Lancet"},{"key":"BFsrep03363_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1086\/509810","volume":"195","author":"A Easton","year":"2007","unstructured":"Easton, A., Haque, A., Chu, K., Lukaszewski, R. & Bancroft, G. J. A Critical Role for Neutrophils in Resistance to Experimental Infection with Burkholderia pseudomallei. Journal of Infectious Diseases 195, 99\u2013107 (2007).","journal-title":"Journal of Infectious Diseases"},{"key":"BFsrep03363_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1128\/IAI.73.2.1106-1115.2005","volume":"73","author":"SL Reckseidler-Zenteno","year":"2005","unstructured":"Reckseidler-Zenteno, S. L., DeVinney, R. & Woods, D. E. The Capsular Polysaccharide of Burkholderia pseudomallei Contributes to Survival in Serum by Reducing Complement Factor C3b Deposition. Infect. Immun. 73, 1106\u20131115 (2005).","journal-title":"Infect. Immun."},{"key":"BFsrep03363_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1128\/IAI.00503-08","volume":"77","author":"S Chanchamroen","year":"2009","unstructured":"Chanchamroen, S., Kewcharoenwong, C., Susaengrat, W., Ato, M. & Lertmemongkolchai, G. Human Polymorphonuclear Neutrophil Responses to Burkholderia pseudomallei in Healthy and Diabetic Subjects. Infect. Immun. 77, 456\u2013463 (2009).","journal-title":"Infect. Immun."},{"key":"BFsrep03363_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nri1785","volume":"6","author":"C Nathan","year":"2006","unstructured":"Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6, 173\u2013182 (2006).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep03363_CR11","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1371\/journal.pmed.0040248","volume":"4","author":"WJ Wiersinga","year":"2007","unstructured":"Wiersinga, W. J. et al. Toll-Like Receptor 2 Impairs Host Defense in Gram-Negative Sepsis Caused by Burkholderia pseudomallei (Melioidosis). PLoS Med 4, e248 (2007).","journal-title":"PLoS Med"},{"key":"BFsrep03363_CR12","doi-asserted-by":"publisher","first-page":"e3494","DOI":"10.1371\/journal.pone.0003494","volume":"3","author":"WJ Wiersinga","year":"2008","unstructured":"Wiersinga, W. J., Wieland, C. W., Roelofs, J. J. T. H. & van der Poll, T. MyD88 Dependent Signaling Contributes to Protective Host Defense against Burkholderia pseudomallei. PLoS ONE 3, e3494 (2008).","journal-title":"PLoS ONE"},{"key":"BFsrep03363_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tcb.2009.06.002","volume":"19","author":"C Bryant","year":"2009","unstructured":"Bryant, C. & Fitzgerald, K. A. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 19, 455\u2013464 (2009).","journal-title":"Trends Cell Biol"},{"key":"BFsrep03363_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 Inflammasome: A Sensor for Metabolic Danger? Science 327, 296\u2013300 (2010).","journal-title":"Science"},{"key":"BFsrep03363_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nature reviews. Immunology 11, 98\u2013107 (2011).","journal-title":"Nature reviews. Immunology"},{"key":"BFsrep03363_CR16","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db06-1650","volume":"56","author":"JA Ehses","year":"2007","unstructured":"Ehses, J. A. et al. Increased Number of Islet-Associated Macrophages in Type 2 Diabetes. Diabetes 56, 2356\u20132370 (2007).","journal-title":"Diabetes"},{"key":"BFsrep03363_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00384-009-0847-3","volume":"25","author":"Y Sunil","year":"2010","unstructured":"Sunil, Y., Ramadori, G. & Raddatzc, D. Influence of NFkappaB inhibitors on IL-1beta-induced chemokine CXCL8 and -10 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC. Int J Colorectal Dis 25, 323\u2013333 (2010).","journal-title":"Int J Colorectal Dis"},{"key":"BFsrep03363_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1128\/IAI.01257-08","volume":"77","author":"K Breitbach","year":"2009","unstructured":"Breitbach, K. et al. Caspase-1 Mediates Resistance in Murine Melioidosis. Infect. Immun. 77, 1589\u20131595 (2009).","journal-title":"Infect. Immun."},{"key":"BFsrep03363_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jinf.2006.05.004","volume":"54","author":"O Oncul","year":"2007","unstructured":"Oncul, O. et al. Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. Journal of Infection 54, 250\u2013256 (2007).","journal-title":"Journal of Infection"},{"key":"BFsrep03363_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s00134-010-1845-1","volume":"36","author":"A Andreasen","year":"2010","unstructured":"Andreasen, A. et al. Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Medicine 36, 1548\u20131555 (2010).","journal-title":"Intensive Care Medicine"},{"key":"BFsrep03363_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome. J Cell Biol 187, 61\u201370 (2009).","journal-title":"J Cell Biol"},{"key":"BFsrep03363_CR22","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1002\/eji.201242526","volume":"42","author":"D Rinchai","year":"2012","unstructured":"Rinchai, D. et al. Production of interleukin-27 by human neutrophils regulates their function during bacterial infection. Eur J Immunol 42, 3280\u20133290 (2012).","journal-title":"Eur J Immunol"},{"key":"BFsrep03363_CR23","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720\u20133732 (2011).","journal-title":"Blood"},{"key":"BFsrep03363_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1463-1326.2001.00152.x","volume":"3","author":"A Jonsson","year":"2001","unstructured":"Jonsson, A., Hallengren, B., Rydberg, T. & Melander, A. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes. Diabetes Obes Metab 3, 403\u2013409 (2001).","journal-title":"Diabetes Obes Metab"},{"key":"BFsrep03363_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/0003-4819-133-1-200007040-00016","volume":"133","author":"RA DeFronzo","year":"2000","unstructured":"DeFronzo, R. A. Pharmacologic Therapy for Type 2 Diabetes Mellitus. Annals of Internal Medicine 133, 73\u201374 (2000).","journal-title":"Annals of Internal Medicine"},{"key":"BFsrep03363_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2249.2006.03229.x","volume":"146","author":"E Hatanaka","year":"2006","unstructured":"Hatanaka, E., Monteagudo, P. T., Marrocos, M. S. M. & Campa, A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clinical & Experimental Immunology 146, 443\u2013447 (2006).","journal-title":"Clinical & Experimental Immunology"},{"key":"BFsrep03363_CR27","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1128\/IAI.00212-12","volume":"80","author":"J Morris","year":"2012","unstructured":"Morris, J. et al. Burkholderia pseudomallei Triggers Altered Inflammatory Profiles in a Whole-Blood Model of Type 2 Diabetes-Melioidosis Comorbidity. Infection and Immunity 80, 2089\u20132099 (2012).","journal-title":"Infection and Immunity"},{"key":"BFsrep03363_CR28","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1073\/pnas.0913087107","volume":"107","author":"EA Miao","year":"2010","unstructured":"Miao, E. A. et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proceedings of the National Academy of Sciences 107, 3076\u20133080 (2010).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep03363_CR29","doi-asserted-by":"publisher","first-page":"e1002452","DOI":"10.1371\/journal.ppat.1002452","volume":"7","author":"I Ceballos-Olvera","year":"2011","unstructured":"Ceballos-Olvera, I., Sahoo, M., Miller, M. A., Barrio, L. d. & Re, F. Inflammasome-dependent Pyroptosis and IL-18 Protect against Burkholderia pseudomallei Lung Infection while IL-1\u03b2 Is Deleterious. PLoS Pathog 7, e1002452 (2011).","journal-title":"PLoS Pathog"},{"key":"BFsrep03363_CR30","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/j.1462-5822.2005.00569.x","volume":"7","author":"GW Sun","year":"2005","unstructured":"Sun, G. W., Lu, J., Pervaiz, S., Cao, W. P. & Gan, Y.-H. Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Cellular Microbiology 7, 1447\u20131458 (2005).","journal-title":"Cellular Microbiology"},{"key":"BFsrep03363_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2003.02076.x","volume":"131","author":"O Hertting","year":"2003","unstructured":"Hertting, O. et al. Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1\u03b2-deficient mice. Clinical & Experimental Immunology 131, 225\u2013233 (2003).","journal-title":"Clinical & Experimental Immunology"},{"key":"BFsrep03363_CR32","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","volume":"25","author":"SM Opal","year":"1997","unstructured":"Opal, S. M. et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25, 1115\u20131124 (1997).","journal-title":"Crit Care Med"},{"key":"BFsrep03363_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/IAI.00930-12","volume":"81","author":"KA Hodgson","year":"2013","unstructured":"Hodgson, K. A., Govan, B. L., Walduck, A. K., Ketheesan, N. & Morris, J. L. Impaired Early Cytokine Responses at the Site of Infection in a Murine Model of Type 2 Diabetes and Melioidosis Comorbidity. Infection and Immunity 81, 470\u2013477 (2013).","journal-title":"Infection and Immunity"},{"key":"BFsrep03363_CR34","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.bmcl.2008.01.127","volume":"18","author":"MP Winters","year":"2008","unstructured":"Winters, M. P. et al. Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides and sulfonylureas as novel antagonists of the CXCR2 receptor. Bioorganic & Medicinal Chemistry Letters 18, 1926\u20131930 (2008).","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"BFsrep03363_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1164\/rccm.200907-1145OC","volume":"182","author":"F Spiller","year":"2010","unstructured":"Spiller, F. et al. Hydrogen Sulfide Improves Neutrophil Migration and Survival in Sepsis via K + ATP Channel Activation. Am. J. Respir. Crit. Care Med. 182, 360\u2013368 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFsrep03363_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/cid\/ciq192","volume":"52","author":"GCKW Koh","year":"2011","unstructured":"Koh, G. C. K. W. et al. Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis. Clinical Infectious Diseases 52, 717\u2013725 (2011).","journal-title":"Clinical Infectious Diseases"},{"key":"BFsrep03363_CR37","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw, R. J. et al. The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin. Science 310, 1642\u20131646 (2005).","journal-title":"Science"},{"key":"BFsrep03363_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12, 408\u2013415 (2011).","journal-title":"Nat Immunol"},{"key":"BFsrep03363_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. in Report of WHO consultation: Part 1 Diagnosis and classification of diabetes mellitus. Diabet Med 15, 539\u2013553 (1998).","journal-title":"Diabet Med"},{"key":"BFsrep03363_CR40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0731-7085(02)00013-4","volume":"28","author":"I Niopas","year":"2002","unstructured":"Niopas, I. & Daftsios, A. C. A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 28, 653\u2013657 (2002).","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"BFsrep03363_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey, C. J. & Turner, R. C. Metformin. New England Journal of Medicine 334, 574\u2013579 (1996).","journal-title":"New England Journal of Medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep03363","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep03363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep03363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:43:36Z","timestamp":1672962216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep03363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep03363"],"URL":"https:\/\/doi.org\/10.1038\/srep03363","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,28]]},"assertion":[{"value":"27 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3363"}}